Potential consequences of widespread antepartal use of ampicillin (Q40838137)

24 September 2017

title

Potential consequences of widespread antepartal use of ampicillin (English)

1 reference

24 September 2017

Towers CV

1 reference

24 September 2017

Carr MH

series ordinal

1 reference

24 September 2017

Padilla G

series ordinal

1 reference

24 September 2017

Asrat T

series ordinal

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

American Journal of Obstetrics and Gynecology

24 September 2017

1 reference

inferred from page(s)

published in

1 reference

24 September 2017

volume

179

1 reference

24 September 2017

1 reference

24 September 2017

page(s)

879-883

1 reference

Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970182-6

Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970182-6

Randomized trial of prophylactic antibiotic therapy after preterm amnion rupture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970182-6

Adjunctive erythromycin treatment for idiopathic preterm labor: results of a randomized, double-blinded, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970182-6

Causes of low birth weight births in public and private patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970182-6

Ampicillin prophylaxis in preterm premature rupture of the membranes: a prospective randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970182-6

Antimicrobial therapy in preterm premature rupture of membranes: results of a prospective, double-blind, placebo-controlled trial of erythromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970182-6

Erythromycin therapy in preterm premature rupture of the membranes: a prospective, randomized trial of 220 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970182-6

Antibiotic therapy in preterm premature rupture of membranes: a randomized, prospective, double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970182-6

10.1016/S0002-9378(98)70182-6

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference